Downregulation of TLR-7 receptor in hepatic and non-hepatic patients with lichen planus

International Journal of Dermatology

Volumn 51, Issue 7, 2012, Pages 785-789

  El Tawdy, Amira ^a   Rashed, Laila ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; TOLL LIKE RECEPTOR 7;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LICHEN PLANUS; MALE; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SCHOOL CHILD; SEX; SKIN BIOPSY; VIRUS DETECTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, VIRAL; CHILD; DOWN-REGULATION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LICHEN PLANUS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TOLL-LIKE RECEPTOR 7; YOUNG ADULT;

EID: 84862702808     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04977.x     Document Type: Article

References (30)

1. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol 1991; 25: 593.
2. Iijima W, Ohtani H, Nakayama T, et al. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5&CXCR3 and carry retrospective chemokine ligand RANTES/CCL5 and IP-10-CXCL10 in there cytolytic granules: a potential self- recruiting mechanism. Am J Pathol 2003; 163: 263.
3. Lodi G, Guiliani M, Majorana A, et al. Lichen planus and hepatitis C virus: a multicenter study of patients with oral lesions and a systematic review. Br J Dermatol 2004; 151: 1172.
4. Carrozzo M, Gandolfo S, Carbone M, et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996; 25: 527-533.
5. Arrieta JJ, Rodriguez Inigo E, Casqueiro M, et al. Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology 2000; 32: 97-103. doi:.
6. Erkek E, Bozdogan O, Olut AI. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 2001; 26: 540-544. doi
7. Nagao Y, Kameyama T, Sata M. Hepatitis C virus RNA detection in oral lichen planus tissue. Acta Derm Venereol 1998; 78: 355-357.
8. Tucker SC, Coulson IH. Lichen planus is not associated with hepatitis C virus infection in patients from North West England. Acta Derm Venereol 1999; 79: 378-379.
9. Hayashi T, Gray CS, Chan M, et al. Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7. Immunology 2009; 106: 2764-2769.
10. Thomsen LL, Topley P, Daly MG, et al. Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery. Vaccine 2004; 22: 1799-1809.
11. Ramakrishna V, Vasilakos JP, Tario JD Jr, et al. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells. J Transl Med 2007; 5: 5.
12. Diebold SS, Massacrier C, Akira S, et al. Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 2006; 36: 3256-3267.
13. Vollmer J, Tluk S, Schmitz C, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med 2005; 202: 1575-1585.
14. Hornung V, Guenthner-Biller M, Bourquin C, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11: 263-270.
15. Sioud M. Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2′-hydroxyl uridines in immune responses. Eur J Immunol 2006; 36: 1222-1230.
16. Chang S, Kodys K, Szabo G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 2010; 51: 35-42.
17. Xu N, Yao H-P, Sun Z, Chen Z. Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. Acta Pharmacol Sin 2008; 29: 239-244.
18. Jurk M, Kritzler A, Schulte B, et al. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides. Eur J Immunol 2006; 36: 1815-1826.
19. Meier A, Alter G, Frahm N, et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81: 8180-8191.
20. Gorden KB, Gorski KS, Gibson SJ, et al. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. J Immunol 2005; 174: 1259-1268.
21. Lee J, Chuang TH, Redecke V, et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003; 100: 6646-6651.
22. Jurk M, Heil F, Vollmer J, et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 2002; 3: 499.
23. Petruzzi M, De Bebedittis M, Loria MP, et al. Immune response in patients with oral lichen planus and HC infection. Int J Immunopathol Pharmacol 2004; 17: 93-98.
24. Scheel B, Braedel S, Probst J, et al. Immunostimulating capacities of stabilized RNA molecules. Eur J Immunol 2004; 34: 537-547.
25. Ito T, Amakawa R, Kaisho T, et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002; 195: 1507-1512.
26. Birmachu W, Gleason RM, Bulbulian BJ, et al. Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists. BMC Immunol 2007; 8: 26.
27. LeBouder E, Rey-Nores JE, Rushmere NK, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003; 171: 6680-6689.
28. Mitsuzawa H, Nishitani C, Hyakushima N, et al. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice. J Immunol 2006; 177: 8133-8139.
29. Miller LS, Sorensen OE, Liu PT, et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 2005; 174: 6137-6143.
30. Li J, Chen J, Tan Z, et al. Expression of TLR9 and its mRNA in the lesions of lichen planus. Immunol Rev 2005; 204: 27-42.